CHARLES TOWN, W.Va., Nov. 23 ReBuilder Medical
Technologies, Inc. (Pink Sheets: RBRM), a provider of treatment for diabetic
peripheral neuropathy and Molluscum Contagiosum, today announced it has
successfully concluded analysis of the recent volatility of their stock price
and presented it to the Board of Directors.
(Logo: http://www.newscom.com/cgi-bin/prnh/20061128/REBUILDERLOGO )
It appears that several institutional and corporate investors possibly got
nervous over the sub-prime housing crisis and liquidated large portions of
their portfolios. "Unfortunately, our equity was included in their programmed
liquidation process. As a result, many individual investors followed suit,
increasing the supply of stock available to purchase and driving down the
price per share," according to David Phillips, Ph.D. CEO.
Meanwhile the company continued its steady growth as evidenced by the
quarterly reports published on pinksheets.com. There was no bad news
whatsoever relative to the actual operations of the company. "We are in
better financial shape, in better marketing shape, in better R&D shape, and in
better PR shape than ever before in our company's history," says Dr. Phillips.
"We have successfully renegotiated certain aspects of our original merger
terms to reduce the possibility of any remaining large corporate holders of
our equities from taking profits and dumping large blocks of our stock on the
market. In addition, many of these original holders of large blocks of our
equities have now liquidated the majority of their shares to individual
investors. We expect that these new individuals may have the best long-term
interests of our company in mind. This could have the desired effect of
stabilizing the stock price and thus reflect the real value of our equities,"
states Dr. Phillips. He concluded his statement by saying, "Because I,
personally, am an insider, I cannot buy my own company's stock. However, if I
could, I would sell my dog if I had to, to buy some."
Beginning on Monday, November 26, 2007, RBRM will be releasing a series of
twelve news releases that will describe several new initiatives that are very
exciting and will help investors have a better understanding of the company's
current success and plans to expand that success in the near future.
Safe Harbor: This letter contains certain forward-looking statements
within the meaning of Section 27A of the Securities Act of 1933, as amended
and Section 21E of the Securities Exchange Act of 1934, as amended, which are
intended to be covered by the safe harbors created thereby. Investors are
cautioned that all forward-looking statements involve risks and uncertainty,
including without limitation, the ability of the Company to successfully
implement its turnaround strategy, changes in costs of raw materials, labor,
and employee benefits, as well as general market conditions, competition and
pricing. Although the Company believes that the assumptions underlying the
forward-looking statements contained herein are reasonable, any of the
assumptions could be inaccurate, and therefore, there can be no assurance that
the forward-looking statements included in this letter will prove to be
accurate. In light of the significant uncertainties inherent in the
forward-looking statements included herein, the inclusion of such information
should not be regarded as representation by the Company or any other person
that the objectives and plans of the Company will be achieved. In assessing
forward-looking statements included herein, readers are urged to carefully
read those statements. When used in the Annual Report on Form 10-K, the words
"estimate," "anticipate," "expect," "believe," and similar expressions are
intended to be forward-looking statements.
SOURCE ReBuilder Medical Technologies, Inc.
Category:
